Skip to content

Correvio Pharma Corp.

CIK 0001036141

← back to feed
Revenue (TTM)
$32.63M
+13.8% YoY FY Dec 2019
Net Income (TTM)
−$35.18M
−112.2% YoY FY Dec 2019
EPS Diluted (TTM)
−$0.90
−13.9% YoY FY Dec 2019
Gross Margin
69.9%
FY Dec 2019
Operating Margin
-84.1%
FY Dec 2019
Net Margin
-107.8%
FY Dec 2019
Free Cash Flow (TTM)
−$27.2M
FY Dec 2019
Cash
$13.3M
FY Dec 2019
Total Debt
$44.93M
FY Dec 2019
Shares Outstanding
55.38M sh
FY Dec 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings